By Indication

Catheter-Associated Bloodstream Infection (CLABSI / CAUTI) Market Analysis

Cross-industry research covering Catheter-Associated Bloodstream Infection (CLABSI / CAUTI) across 1 market reportspanning Pharmaceuticals.

1 Reports

1 Industries

Reports Covering Catheter-Associated Bloodstream Infection (CLABSI / CAUTI)

Hospital Acquired Infection Control Market to Reach USD 41.6B by 2033 at 6.4% CAGR

Pharmaceuticals·Market: USD 25.3 Billion (2025)·CAGR: 6.4%

CLABSI and CAUTI together generate significant antimicrobial drug spend and device-coating material demand. Antimicrobial catheter coatings, a segment where Heraeus's precious-metal materials science has application (wikidata:Q553935), represent a high-margin adjacency. CMS Hospital-Acquired Condition (HAC) Reduction Program financial penalties create a payer-driven procurement incentive for prevention-focused products.

15%

Market Share

6.3%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments